Rallybio RLYB
NASDAQ RLYB
$17.08 +0.32 (+1.91%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rallybio (RLYB) Selling, General & Administrative (2020 - 2026)

Updated

Rallybio (RLYB) posted Selling, General & Administrative of $4.9 million for Q2 2026, up 16.7% from $4.2 million a year earlier but down 19.4% from the prior quarter.

Analysis

Rallybio (RLYB) Selling, General & Administrative (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Rallybio was $16.94 million, up 1.2% year-over-year; for FY2025, it came in at $14.33 million, down 27.0% from FY2024.

  • Annual Selling, General & Administrative has declined for three consecutive years, though with a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
  • In prior years, Rallybio's Selling, General & Administrative was $19.63 million in FY2024 (-22.7%), $25.39 million in FY2023 (-6.6%), $27.2 million in FY2022 (+45.1%) and $18.74 million in FY2021 (+144.2%).
  • Quarterly Selling, General & Administrative has run from a low of $2.98 million in Q4 2025 to a high of $7.48 million in Q2 2022 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in two of the last eight quarters, with an average decline of 11.0%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 217.8%; the weakest was Q1 2025, with a decline of 39.3%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $6.07 million (Q1 2026), $2.98 million (Q4 2025) and $2.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Rallybio 90.64 Mn 90.64 Mn - 4.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.90 Mn
Mar 31, 2026 6.07 Mn
Dec 31, 2025 2.98 Mn
Sep 30, 2025 2.99 Mn
Jun 30, 2025 4.20 Mn
Mar 31, 2025 4.16 Mn
Dec 31, 2024 4.26 Mn
Sep 30, 2024 4.13 Mn
Jun 30, 2024 4.39 Mn
Mar 31, 2024 6.85 Mn
Dec 31, 2023 5.19 Mn
Sep 30, 2023 6.08 Mn
Jun 30, 2023 6.95 Mn
Mar 31, 2023 7.17 Mn
Dec 31, 2022 6.30 Mn
Sep 30, 2022 6.75 Mn
Jun 30, 2022 7.48 Mn
Mar 31, 2022 6.67 Mn
Dec 31, 2021 6.22 Mn
Sep 30, 2021 5.02 Mn
API Access

Rallybio Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RLYB&period=max&api_key=YOUR_API_KEY